Navigation Links
MetaStat, Inc. Executes Two New Licenses
Date:4/27/2012

s diagnostic approach may be applicable in up to 80% of all solid tumor cancers, including prostate, lung, colorectal, head and neck, and pancreatic.  Most significantly, we believe our platform technology provides us with targets of intervention in key pathways for the development of the first therapies that may preemptively reduce or eliminate metastasis thereby dramatically reducing fatalities.

Our technology platform and corresponding products result from over 15 years of collaboration involving four highly respected scientific institutions. We are unique and differentiated in the marketplace because our discoveries are based on direct microscopic visualization of living, functioning cancer tumors. We have observed the behaviors and mechanisms used by metastatic cells as they migrate to and penetrate blood vessels, where they are subsequently carried away to establish distant site metastases.

For More Information, Contact:

Warren C. Lau
President & CEO
MetaStat, Inc.
(281) 363-0003


'/>"/>
SOURCE MetaStat, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PhotoVoltaic Solar Cells, Inc. Completes Share Exchange with MetaStat, Inc.
2. MetaStat, Inc. Completes Share Exchange with PhotoVoltaic Solar Cells, Inc.
3. Ampio Pharmaceuticals Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane™ in South Korea
4. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
5. Adeona Executes Manufacturing and Supply Agreement with TG United for reaZin™
6. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
7. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
8. Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
9. Obecure Executes Licensing and Clinical Supply Agreement With Farmaceutici-Formenti SPA for Extended Release Formulation of Betahistine
10. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
11. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 29, 2015 Research and ... "Pharmaceutical Packaging Market in North America 2015-2019" ... market in North America to ... 2014-2019. International regulations regarding safe drug ... which in turn fuels adoption of sustainable packaging. Various ...
(Date:7/6/2015)... DUBLIN , June 29, 2015 ... the addition of the "Urinary Slings Market in ... The analysts forecast the Urinary Slings market in ... percent over the period 2014-2019. This report covers ... Urinary Slings market in the US for the period ...
(Date:7/6/2015)... July 6, 2015 Moerae Matrix, a ... therapeutics that target inflammation and fibrosis, today announced ... PhD, as Chief Medical Officer. ... strategy and programs, which include a pipeline of ... fibrotic conditions.  Bill is an accomplished strategist and ...
Breaking Medicine Technology:North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2
... and LOS ANGELES, April 18, 2007,/PRNewswire-FirstCall/ -- ... studies, one identifying a functional,biomarker for its ... preclinical anti-tumor activity with its,Bruton's tyrosine kinase ... the American Association for Cancer Research (AACR),2007 ...
... Equivalent and Irradiated Tumor,Cells Increased Long-Term Survival ... a,Preclinical Model of Brain Cancer--, LOS ANGELES ... Peregrine Pharmaceuticals, Inc. , a,clinical stage biopharmaceutical ... of cancer and hepatitis C,virus (HCV) infection, ...
Cached Medicine Technology:Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6
(Date:7/6/2015)... Angeles, CA (PRWEB) , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled ... by the time they turn age 35 a quarter of all women in the U.S. will ... hair loss is stigmatized and rarely discussed. One woman, a former beauty queen, who ...
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to Cover: ... there is a large gap between the unmet health priorities in the region ... outcomes and reduce unnecessary or ineffective treatments or procedures. , This milestone conference, ...
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is proud to announce that ... Award on behalf of the department of Family Practice. , “This award is a ... practicing in. The technology is changing so rapidly and we are also developing new ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. ... serious medical conditions. Screenings are affordable and accurate and run about an hour ...
(Date:7/6/2015)... CO (PRWEB) , ... July 06, 2015 , ... Health ... and the ability of the medical field to access and use this “Big Data” ... Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System in ...
Breaking Medicine News(10 mins):Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5
... Alzheimer,s CaregiversSAN FRANCISCO, April 27 , WHAT: The community ... panel discussion of HBO Documentary Films, THE ALZHEIMER,S, ... at Warner Bros. Studios in, ... films director, Bill Couturie and producer, Anne Sandkuhler, ...
... Opportunity to Maximize Shareholder Value Is Through A Sale ... Anchor Capital, a stockholder of BioScrip, Inc. (Nasdaq: ... sent a letter to the Board of Directors of ... value would be maximized through simultaneous i) cost rationalizations ...
... MONROVIA, Calif., April 27 STAAR Surgical Company (Nasdaq: STAA ) ... fiscal 2009 on Tuesday, May 5, 2009 ... The Company will host a conference call and webcast ... at 4:30 p.m. Eastern / 1:30 p.m. Pacific to ...
... new research reported in the journal Gut ... may ease symptoms of anxiety in people with ... CFS received daily supplements of either Lactobacillus casei ... Compared to the placebo group, those receiving the ...
... Public Health EmergencyHARRISBURG, Pa., April 27 ... to contain the impact of an outbreak of swine ... a national public health emergency in the United States.The ... and health care providers of recommended steps to prepare ...
... 27 Daily exposure to toxins in the products ... and insecticides, are creating a toxic load on our ... asthma. In light of increased awareness of our environmental ... ) announced today the release of three new ...
Cached Medicine News:Health News:HBO, Warner Bros. Employee Initiatives and the Alzheimer's Association, California Southland Chapter Present a Free, Public, Advance Screening of THE ALZHEIMER'S PROJECT: 'Caregivers' 2Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 2Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 3Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 4Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 5Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 6Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 7Health News:STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call 2Health News:New Study Shows Supplementing With Probiotics May Ease Anxiety 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 3Health News:Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health 2
... The pharmaceutical subset of the ... 21 of the Code of ... and final rules published in ... updated regularly as released by ...
... measuring principle - Pupil Zone Imaging Method ... offers high accuracy and reliability in refraction ... measurement (3.3 mm) using a mire ring, ... 4 points, both of which offer reliable ...
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
... The ISI Free-Standing upper extremity table ... and in-office procedures. This table features ... and an extra-durable, hour-glass shaped Lexan ... stable -- this table is our ...
Medicine Products: